Taylor Leavitt

President, Leavitt Equity Partners

Taylor Leavitt is President of Leavitt Equity Partners, an affiliated value-add private equity fund that seeks to invest capital into growth and lower mid-market opportunities that align with the firm’s core beliefs about the future of health care. Taylor also leads the Leavitt Partners Equity Practice which directs the management of the firm’s portfolio holdings, due diligence processes, and relationships with other private equity funds and financial institutions.

Taylor has led the firm’s equity and investment activities since inception, which include equity positions in more than a dozen companies, including HealthEquity, Independent Living Systems, Health Integrated, Cogent Healthcare, RSA Medical, and others.

In 2014, Taylor led the effort of launching Leavitt Equity Partners and successfully raised its first $100 million fund. LEP has made investments into growing health care companies in health information technology, value-based care, pharmacy services, population analytics, health diagnostics and rural medicine.

Prior to joining Leavitt Partners, Taylor worked for ZARS Pharma, a venture capital-funded pharmaceutical company engaged in corporate licensing and business development operations. While at ZARS, Taylor identified, negotiated, and executed strategic corporate transactions on a global basis, including merger and acquisitions, national and international product licenses, IP and technology licenses, and R&D alliances. Prior to ZARS Pharma, Taylor was a founding employee for the Park City Center for Public Policy. In other capacities, Taylor has worked with Epic Venture Capital, SAIC, and Keystone Global Investment LLC.

Taylor received a master’s degree in business administration from the UCLA Anderson School of Business with an emphasis in private equity and entrepreneurship. He graduated magna cum laude from Utah State University studying finance, economics, and international business.